Why the sell-off in big tech looks overdone

Munro’s Nick Griffin on why he prefers Alphabet and Amazon over Meta, shorting industrials and Chinese equities, and his top picks for the energy transition.

Why the sell-off in big tech looks overdone

November 3, 2022
Munro’s Nick Griffin on why he prefers Alphabet and Amazon over Meta, shorting industrials and Chinese equities, and his top picks for the energy transition.
Read Transcript

Nick Griffin is the Chief Investment Officer of Munro Partners. Mr Griffin will present an investment idea at the Sohn Hearts & Minds conference in Tasmania on November 18.

Has the sell-off in the global tech giants been overdone?

The global tech giants are in the penalty box right now. After a decade of strong growth, with most of them reaching $US1 trillion in market cap, they have ultimately become more sensitive to the macroeconomy than they have been previously due to their enlarged size. As the economy slows, so too has their revenue growth.

However, what has surprised us a little is not their slowing growth but their inability to manage the cost base better in a downturn. As predominately digital businesses, they should be able to adjust the cost base better than more traditional companies. But so far, while management has talked a good game like hiring freezes, they have continued to spend.

Meta (previously Facebook) is the most egregious example, who looks set to spend in excess of $US100 billion in corporate expenses and capex in 2023 building out founder Mark Zuckerberg’s metaverse ambitions.

While the sell-off does look overdone, the decision from here is which one of these companies can manage costs to a slowing revenue environment and ultimately improve shareholder returns. For us, Amazon and Google have the management teams and the opportunity to do this and look best placed to solve this over the coming quarters. Meta, on the other hand, looks likely to be stuck in the penalty box until the metaverse investments start to pay off … if at all.

Which stock focused on the clean energy transition are you most bullish on?

For us, the obvious winners are utilities that will need to be incentivised to build the transition – so think the renewable power that will drive the clean economy. Here we like companies like Nextera Energy in the US and RWE in Germany.

Beyond the utilities, there are also many opportunities in electric vehicles and home generation. But the ones we are most bullish on are the forgotten ones, where some don’t realise how important they are to the transition.

Here we would flag LNG. While gas is a fossil fuel, it is essential to replace coal in countries like China, India and more recently Europe. Cheniere Energy, based in the US, is the second largest LNG exporter in the world and looks well-placed to fill this need over the coming decades.

What’s a stock you’d like to own but don’t for some reason?

The semiconductor stocks have been horrible in 2022 as the economy has slowed, and customers have begun to unwind the double ordering they were doing during the supply shortages in 2021. This will ultimately lead to a great opportunity to invest in an area we see as the oil of the digital economy.

A company we like but had missed in the previous semiconductor cycle is Marvel Technologies. The company focuses on networking products that are vital to how we connect to the cloud. As cloud computing grows, Marvel grows, and we see nothing to suggest this opportunity has gone over the medium term.

Which areas of the market are you shorting, and why?

Short exposure is relatively small currently, but for the ones we do have, there are two main areas we are currently focused on. The first is industrials, where we think the slowing economy that has gone through housing, retail and technology stocks will ultimately lead to a slowing capex environment for most industrials.

The second area is China, specifically Chinese listed equities. While clearly not a new idea, we suspect that government policy will ultimately see capital continue to leave the country, pressuring the equity market and the ability of Chinese corporates to raise financing.

Which stock produced the biggest surprise in the Q3 earnings season?

For us, it was Amazon. We are long-term supporters of the company, and while we halved our holding at the start of the year, we were looking to get bigger in the holding at some point and were hopeful that new CEO Andy Jassy would be able to show some more concrete progress towards improved profitability in the retail business.

Unfortunately, the economic slowdown and some over-investment during 2021 means it is taking longer to turn things around, and profitability shrank in the third quarter versus the second quarter. While we remain confident that Jassy can right the ship, it is taking longer than we hoped, and that was our biggest disappointment.

Which stocks have you recently added?

While we are a little late, we recently added pharmaceutical mega caps, Eli Lilly and Novo Nordisk. Both companies are at the forefront of commercialising GLP 1’s for the treatment of obesity.

Previously, pharmaceuticals were used to treat less than 5 per cent of morbidly obese patients. However, with the introduction of easy-to-use drugs such as Ozempic and Mounjaro, we now see this treatment expanding to the wider population to prevent Type 2 diabetes and the related co-morbidities.

Both companies appear to have a blockbuster on their hands here, and we are excited about the earnings growth ahead.

Favourite local bar/restaurant in Melbourne?

Lupino, Little Collins St. Richard Lodge and his team make the best crumbed veal in Melbourne and always have a good service and a good Barbera to accompany it.

Any podcasts or TV shows you’d recommend?

Apart from the Invest in the Journey podcast from Munro, I recently started listening to a podcast called The Knowledge Project, which is full of helpful insights from experts on how to make better decisions, keep your head and continue being nice to your family when things aren’t quite going the way you want them to, which has been happening a bit in 2022!

 

 

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by AFR, published on 3 November 2022. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Nick Griffin is the Chief Investment Officer of Munro Partners. Mr Griffin will present an investment idea at the Sohn Hearts & Minds conference in Tasmania on November 18.

Has the sell-off in the global tech giants been overdone?

The global tech giants are in the penalty box right now. After a decade of strong growth, with most of them reaching $US1 trillion in market cap, they have ultimately become more sensitive to the macroeconomy than they have been previously due to their enlarged size. As the economy slows, so too has their revenue growth.

However, what has surprised us a little is not their slowing growth but their inability to manage the cost base better in a downturn. As predominately digital businesses, they should be able to adjust the cost base better than more traditional companies. But so far, while management has talked a good game like hiring freezes, they have continued to spend.

Meta (previously Facebook) is the most egregious example, who looks set to spend in excess of $US100 billion in corporate expenses and capex in 2023 building out founder Mark Zuckerberg’s metaverse ambitions.

While the sell-off does look overdone, the decision from here is which one of these companies can manage costs to a slowing revenue environment and ultimately improve shareholder returns. For us, Amazon and Google have the management teams and the opportunity to do this and look best placed to solve this over the coming quarters. Meta, on the other hand, looks likely to be stuck in the penalty box until the metaverse investments start to pay off … if at all.

Which stock focused on the clean energy transition are you most bullish on?

For us, the obvious winners are utilities that will need to be incentivised to build the transition – so think the renewable power that will drive the clean economy. Here we like companies like Nextera Energy in the US and RWE in Germany.

Beyond the utilities, there are also many opportunities in electric vehicles and home generation. But the ones we are most bullish on are the forgotten ones, where some don’t realise how important they are to the transition.

Here we would flag LNG. While gas is a fossil fuel, it is essential to replace coal in countries like China, India and more recently Europe. Cheniere Energy, based in the US, is the second largest LNG exporter in the world and looks well-placed to fill this need over the coming decades.

What’s a stock you’d like to own but don’t for some reason?

The semiconductor stocks have been horrible in 2022 as the economy has slowed, and customers have begun to unwind the double ordering they were doing during the supply shortages in 2021. This will ultimately lead to a great opportunity to invest in an area we see as the oil of the digital economy.

A company we like but had missed in the previous semiconductor cycle is Marvel Technologies. The company focuses on networking products that are vital to how we connect to the cloud. As cloud computing grows, Marvel grows, and we see nothing to suggest this opportunity has gone over the medium term.

Which areas of the market are you shorting, and why?

Short exposure is relatively small currently, but for the ones we do have, there are two main areas we are currently focused on. The first is industrials, where we think the slowing economy that has gone through housing, retail and technology stocks will ultimately lead to a slowing capex environment for most industrials.

The second area is China, specifically Chinese listed equities. While clearly not a new idea, we suspect that government policy will ultimately see capital continue to leave the country, pressuring the equity market and the ability of Chinese corporates to raise financing.

Which stock produced the biggest surprise in the Q3 earnings season?

For us, it was Amazon. We are long-term supporters of the company, and while we halved our holding at the start of the year, we were looking to get bigger in the holding at some point and were hopeful that new CEO Andy Jassy would be able to show some more concrete progress towards improved profitability in the retail business.

Unfortunately, the economic slowdown and some over-investment during 2021 means it is taking longer to turn things around, and profitability shrank in the third quarter versus the second quarter. While we remain confident that Jassy can right the ship, it is taking longer than we hoped, and that was our biggest disappointment.

Which stocks have you recently added?

While we are a little late, we recently added pharmaceutical mega caps, Eli Lilly and Novo Nordisk. Both companies are at the forefront of commercialising GLP 1’s for the treatment of obesity.

Previously, pharmaceuticals were used to treat less than 5 per cent of morbidly obese patients. However, with the introduction of easy-to-use drugs such as Ozempic and Mounjaro, we now see this treatment expanding to the wider population to prevent Type 2 diabetes and the related co-morbidities.

Both companies appear to have a blockbuster on their hands here, and we are excited about the earnings growth ahead.

Favourite local bar/restaurant in Melbourne?

Lupino, Little Collins St. Richard Lodge and his team make the best crumbed veal in Melbourne and always have a good service and a good Barbera to accompany it.

Any podcasts or TV shows you’d recommend?

Apart from the Invest in the Journey podcast from Munro, I recently started listening to a podcast called The Knowledge Project, which is full of helpful insights from experts on how to make better decisions, keep your head and continue being nice to your family when things aren’t quite going the way you want them to, which has been happening a bit in 2022!

 

 

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by AFR, published on 3 November 2022. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Disclaimer: This material has been prepared by Australian Financial Review, published on Nov 03, 2022. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lancaster sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.